Editor profile
Managing Editor, Digital Health
Julian Sterling analyzes the evolution of global telemedicine platforms and health data management systems. He focuses on the digital transformation of patient care delivery.
julian.sterling@medtechdaily.orgBased on a joint survey by AMA and Medscape, this article analyzes the current clinical use of wearable data among global physicians and the barriers to its integration, exploring the impact of key factors such as payment, regulation, and workflow on the medical technology market.
According to a Future Market Insights report, the global medical IoT market is expected to reach US$280.5 billion by 2026, increasing to US$1,164.8 billion by 2036, with a compound annual growth rate of 15.3%. Hardware accounts for 46%, telemedicine for 32%, and India is the fastest-growing market.
The global clinical trial market size is expected to reach $143.46 billion by 2033, with AI and decentralized models reshaping the drug development landscape.
This article reviews the evolution of digital health from early mobile health to the present, analyzes how technology is reshaping the healthcare industry, and looks forward to future trends in medical innovation in the AI era.
Based on a systematic review of global AI medical device regulation and research from 2015 to 2025, this paper analyzes the regulatory pathways of the United States, the European Union, China, Japan, and South Korea, and explores how policies affect the medical technology industry.
According to the latest Healthcare Foresights report, the global healthcare digital transformation market is expected to reach $270.9 billion by 2035, with a compound annual growth rate of 14.13%. This article analyzes how key technologies such as AI, cloud platforms, and telemedicine are driving transformation in the healthcare industry, and explores market opportunities and challenges.
In 2026, the biotech and life sciences industry reaches a critical turning point. From AI-driven drug discovery to clinical breakthroughs in gene editing, from regulatory reforms to global capital flows, these 26 trends are reshaping the future of medical innovation.
From FDA to the EU AI Act: A Decade of Evolution and Industry Impact of AI Medical Device Regulatory Policies Across the World's Five Major Economies.
This article analyzes the application of AI in the healthcare industry from an industrial perspective, focusing on how CRM platforms represented by Salesforce drive digital transformation in healthcare through AI agents, data integration, and patient relationship management, while also exploring development trends over the next 3-5 years.
The U.S. FDA has selected Dexcom as the first participant in the TEMPO digital health device pilot. The AI-driven blood glucose management program will be granted exemption from certain premarket approval requirements, while collecting real-world data through Medicare.
The self-disinfecting medical device market is rapidly expanding at a compound annual growth rate of 14%, driven by rising hospital infection rates, a surge in surgical volumes, and increasing healthcare expenditure. This article analyzes market dynamics, key technology trends, and regional competitive landscape.
AI is reshaping the healthcare industry, from diagnostic assistance to patient management, with technology implementation accelerating. This article analyzes key trends, market impacts, and future challenges.
According to a sharing by Public Intelligence CEO Peter Julius on HIMSS TV, early trials of the social robot Hana-chan have shown that it can enhance patients' emotional well-being and help aggressive patients relax. This article analyzes the significance of this progress for the healthcare technology industry, the affected companies, and future trends.
Driven by personalized medicine, regulatory maturity, and declining costs of multi-laser systems, the global additive manufacturing market for medical devices is expected to grow at a compound annual growth rate of 15–20% from 2026 to 2035. Orthopedic implants and surgical guides account for 55–70% of revenue, and in-house 3D printing laboratories in hospitals are accelerating in adoption.
This week's healthcare technology industry highlights: Merck KGaA acquires Bio-Techne for $11.3 billion, expanding its life science tools business; Insilico Medicine and SK Biopharmaceuticals launch a $2.5 billion AI neuroimmune drug collaboration; Anthropic introduces the Claude Science platform for antibiotic design; Nipah virus and schistosomiasis vaccines achieve clinical progress.
The research team developed a clinical large language model named AI4Doctor, which significantly improved AI's decision-making ability in complex diagnosis scenarios by integrating electronic medical record data and doctor experience.
According to the latest PwC report, healthcare technology M&A transaction value reached $36.5 billion in the first half of 2026, continuing the ten-year high trend set in 2025, with strategic buyers focusing on high-growth areas and private equity capital actively entering the market.
According to the latest PwC report, the total value of medical technology M&A transactions in the first half of 2026 reached $36.5 billion, led by Boston Scientific's acquisition of Penumbra and Danaher's acquisition of Masimo, indicating that the industry's M&A momentum remains strong.
Deloitte's latest research shows that diagnostic manufacturers are shifting from traditional product suppliers to a B2B2C model, with AI, EHR workflow integration, and interoperability becoming key to the next stage of growth.